Choksi Laboratories Ltd vs Kmc Speciality Hospitals India Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Oct 25, 2026

Key Highlights

The Latest Trading Price of Choksi Laboratories Ltd is ₹ 207.75 as of 23 Oct 15:30 . The P/E Ratio of Choksi Laboratories Ltd changed from 84.7 on March 2022 to 36.7 on March 2026 . This represents a CAGR of -15.40% over 5 yearsThe P/E Ratio of KMC Speciality Hospitals (India) Ltd changed from 28 on March 2021 to 27.4 on March 2026 . This represents a CAGR of -0.36% over 6 years The Market Cap of Choksi Laboratories Ltd changed from ₹ 5.5 crore on March 2021 to ₹ 72.16 crore on March 2026 . This represents a CAGR of 53.58% over 6 yearsThe Market Cap of KMC Speciality Hospitals (India) Ltd changed from ₹ 355.56 crore on March 2021 to ₹ 1284 crore on March 2026 . This represents a CAGR of 23.87% over 6 years The revenue of Choksi Laboratories Ltd for the Jun '26 is ₹ 12.08 crore as compare to the Mar '26 revenue of ₹ 12.88 crore. This represent the decline of -6.21% The revenue of KMC Speciality Hospitals (India) Ltd for the Jun '26 is ₹ 93.58 crore as compare to the Mar '26 revenue of ₹ 84.16 crore. This represent the growth of 11.19% The ebitda of Choksi Laboratories Ltd for the Jun '26 is ₹ 3.3 crore as compare to the Mar '26 ebitda of ₹ 3.71 crore. This represent the decline of -11.05% The ebitda of KMC Speciality Hospitals (India) Ltd for the Jun '26 is ₹ 30.29 crore as compare to the Mar '26 ebitda of ₹ 27.78 crore. This represent the growth of 9.04% The net profit of Choksi Laboratories Ltd changed from ₹ 0.42 crore to ₹ 0.58 crore over 9 quarters. This represents a CAGR of 15.43% The net profit of KMC Speciality Hospitals (India) Ltd changed from ₹ 5.51 crore to ₹ 16.57 crore over 9 quarters. This represents a CAGR of 63.12% The Dividend Payout of Choksi Laboratories Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe Dividend Payout of KMC Speciality Hospitals (India) Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 years .

About Choksi Laboratories Ltd

Choksi Laboratories Limited, incorporated on 29 January, 1993 provides contract testing and analytical services.
CLL is a group of research laboratories and consulting offices, offering analysis, calibration, pollution control, research and consultancy services to a broad spectrum of industries.
The Company analyses, for its clients, or as a regulatory requirement pharmaceuticals, food and agricultural products, construction materials, chemicals, Calibration and environment Monitoring services. The Company currently has facilities for analysis of over 1000 products and materials, with more being added every day.
It provides calibration of production & quality control equipment with traceability to national / international standards.
This means that the equipment are precise and therefore reducing the probability of end-product defects / rejects.

About KMC Speciality Hospitals (India) Ltd

KMC Speciality Hospitals (India) Limited was originally incorporated as 'Advanced Medical Care Private Limited' on December 31, 1982 and was converted into a Public Limited Company on July 15, 1988.
The name of the Company was changed to 'Seahorse Hospitals Limited' on March 21, 1995 and to its current name 'KMC Speciality Hospitals (India) Limited' with effect from October 24, 2008. The Company is a part of the KMC Group of Hospitals based at Tiruchirappalli.
The Company is a super speciality hospital based in Trichy, belonging to the Kauvery Hospitals Group.
The Company is primarily engaged in the business of rendering medical and healthcare services.
It provide quality healthcare to patients in key specialty areas such as Neurosurgery, Cardiovascular & thoracic surgery, Orthopedics, Plastic and Reconstructive Surgery, Gynecology, Neonatology and Nephrology (including renal transplants).

FAQs for the comparison of Choksi Laboratories Ltd and KMC Speciality Hospitals (India) Ltd

Which company has a larger market capitalization, Choksi Laboratories Ltd or KMC Speciality Hospitals (India) Ltd?

Market cap of Choksi Laboratories Ltd is 144 Cr while Market cap of KMC Speciality Hospitals (India) Ltd is 2,351 Cr

What are the key factors driving the stock performance of Choksi Laboratories Ltd and KMC Speciality Hospitals (India) Ltd?

The stock performance of Choksi Laboratories Ltd and KMC Speciality Hospitals (India) Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Choksi Laboratories Ltd and KMC Speciality Hospitals (India) Ltd?

As of October 25, 2026, the Choksi Laboratories Ltd stock price is INR ₹207.75. On the other hand, KMC Speciality Hospitals (India) Ltd stock price is INR ₹144.2.

How do dividend payouts of Choksi Laboratories Ltd and KMC Speciality Hospitals (India) Ltd compare?

To compare the dividend payouts of Choksi Laboratories Ltd and KMC Speciality Hospitals (India) Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.